Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Gastroenterology. 2023 Apr 29;165(2):463–472.e5. doi: 10.1053/j.gastro.2023.04.025

Table 2.

Predictors of (A) fibrosis progression and (B) fibrosis regression

(A) Predictors of fibrosis progression Hazard Ratio (95% CI) P-value
 T2DM, unadjusted 1.45 (1.04 – 2.03) 0.03
 T2DM, adjusted for age and sex 1.42 (1.00 – 2.00) 0.05
 T2DM, adjusted for age, sex, BMI, and Hispanic race/ethnicity 1.52 (1.07 – 2.17) 0.02
 T2DM, adjusted for age, sex, BMI, Hispanic race/ethnicity, and baseline fibrosis stage 1.69 (1.17 – 2.43) 0.005
(B) Predictors of fibrosis regression Hazard Ratio (95% CI) P-value
 T2DM, unadjusted 1.15 (0.77 – 1.71) 0.49
 T2DM, adjusted for age and sex 1.36 (0.90 – 2.07) 0.15
 T2DM, adjusted for age, sex, BMI, and Hispanic race/ethnicity 1.38 (0.90 – 2.11) 0.14
 T2DM, adjusted for age, sex, BMI, Hispanic race/ethnicity, and baseline fibrosis stage 1.29 (0.84 – 1.99) 0.24

Abbreviation: T2DM, type 2 diabetes mellitus; BMI, body mass index